Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Shasun Pharmaceuticals Ltd

+ Add to Watchlist

SAPH:IN

373.50 INR 2.90 0.77%

As of 02:13:52 ET on 06/02/2015.

Snapshot for Shasun Pharmaceuticals Ltd (SAPH)

Open: 379.80 Day's Range: 368.35 - 381.50 Volume: 113,726
Previous Close: 376.40 52wk Range: 134.20 - 391.50 1-Yr Rtn: +156.75%

Stock Chart for SAPH

No chart data available.
  • SAPH:IN 373.00
  • 1D
  • 1M
  • 1Y
376.40
Interactive SAPH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SAPH

Current P/E Ratio (ttm) 93.2331
Estimated P/E(03/2016) 77.3389
Relative P/E vs. SENSEX 4.1930
Earnings Per Share (INR) (ttm) 3.9900
Est. EPS (INR) (03/2016) 4.8100
Est. PEG Ratio -
Market Cap (M INR) 22,366.07
Shares Outstanding (M) 60.12
30 Day Average Volume 294,267
Price/Book (mrq) 5.9223
Price/Sale (ttm) 1.7718
Dividend Indicated Gross Yield 0.27%
Cash Dividend (INR) 1.0000
Dividend Ex-Date 07/30/2014
5 Year Dividend Growth -
Next Earnings Announcement 08/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SAPH

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for SAPH

Shasun Pharmaceuticals Ltd. manufactures and develops active pharmaceutical ingredients and their intermediates. The Company produces ibuprofen derivatives, ranitidine and nizatidine and exports them to North America, Europe, Asia and Latin America.

S HariharanChief Financial OfficerS Abhaya KumarManaging Director
S DevendraExecutive DirectorS Vimal KumarExecutive Director
More Company Profile & Key Executives for SAPH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil